Androgen receptor pathway inhibitors, prostate cancer, and older adults: a global Young International Society of Geriatric Oncology drug review
Open Access
- 28 January 2023
- journal article
- review article
- Published by SAGE Publications in Therapeutic Advances in Medical Oncology
- Vol. 15
Abstract
Prostate cancer is a disease of older adults that has undergone a significant therapeutic paradigm shift in the last decade with the emergence of novel androgen receptor pathway inhibitors (ARPis). One of the more commonly used ARPis is enzalutamide. This drug, along with darolutamide and apalutamide, initially received approvals in the metastatic castrate-resistant prostate cancer setting but is now utilized frequently in the metastatic castrate-sensitive and non-metastatic castration-resistant settings. Landmark phase III data illustrating ARPi efficacy in older adults are limited to those with excellent performance status. However, its role in unfit older prostate cancer patients remains to be explored in the context of a narrative review. This first-of-its-kind drug review aims to shed light on the most up-to-date evidence behind the unique toxicity profile of ARPis in the context of geriatric vulnerabilities such as cognitive and functional impairment, along with potential solutions and supporting evidence that exists to circumvent these issues in the vulnerable older adult.Keywords
Funding Information
- Conquer Cancer Foundation (2022YIA-0188919328)
This publication has 97 references indexed in Scilit:
- Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 studyThe Lancet Oncology, 2012
- Impact and Feasibility of a Comprehensive Geriatric Assessment in the Oncology SettingAmerican Journal of Clinical Oncology, 2012
- Comprehensive Geriatric Assessment in the Decision-Making Process in Elderly Patients With Cancer: ELCAPA StudyJournal of Clinical Oncology, 2011
- Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patientsCritical Reviews in Oncology/Hematology, 2011
- Fatigue, Function, and Mortality in Older AdultsThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2010
- Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 studyThe Lancet, 2010
- The Burden of Cardiovascular Disease in the Elderly: Morbidity, Mortality, and CostsClinics in Geriatric Medicine, 2009
- Does a Geriatric Oncology Consultation Modify the Cancer Treatment Plan for Elderly Patients?The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2008
- Annual Report to the Nation on the Status of Cancer, 1975–2002, Featuring Population-Based Trends in Cancer TreatmentJNCI: Journal of the National Cancer Institute, 2005
- A comprehensive geriatric intervention detects multiple problems in older breast cancer patientsCritical Reviews in Oncology/Hematology, 2004